Clinical Trials for Mesothelioma Patients—A Study of Safety and Tolerability of Intravenous CRS-207: Exclusion Criteria
Here is some free information on mesothelioma research from mesothelioma lawyers. Learn about the exclusion criteria for a current clinical trial about the safety and tolerability of intravenous CRS-207 in patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Exclusion Criteria:
1. History of infection with Listeria, prior
vaccination with a listeria-based vaccine, or a positive fecal culture of
Listeria at screening
2. Currently have or have history of certain
study-specified heart, liver, kidney, lung, neurological, immune or other
medical conditions
3. Allergy to penicillin or yeast or other component of
the study drug product (e.g., glycerol)
4. Clinical metabolic or laboratory
abnormalities defined as Grade 3 or 4 of the National Cancer Institute's (NCI's)
Common Terminology Criteria for Adverse Events (CTCAE), version 3.0
5.
Artificial (prosthetic) joint or other artificial implant or devices that cannot
be easily removed
6. Known coagulation (blood clotting) disorder or recent
thrombotic event
7. Certain types of blood transfusions within 14 days prior
to receiving study drug or a condition requiring regular blood transfusions more
than twice per month
8. Taking the following
medications:
Anti-coagulation medications
Systemically active steroids
for more than 2 days within 28 days prior to receiving study drug
More than
325 mg per day of aspirin
More than 2 g per day of acetaminophen
Systemic
antibiotics within 14 days prior to receiving study drug
Another
investigational product within 28 days prior to receiving study drug
9.
Major surgery or significant traumatic injury (or unhealed surgical wounds)
occurring within 28 days prior to receiving study drug, or planned surgery
requiring general anesthesia
10. Infection with HIV, hepatitis B or C, or
HTLV-1 (human t-lymphotropic virus type 1) at screening
11. Pregnant or
lactating, or close contact with pregnant women or newborn babies
12.
Conditions, including alcohol or drug dependence, intercurrent illness, or lack
of sufficient peripheral venous access, that would affect the patient's ability
to comply with study visits and procedures
If you have been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.

Patient inclusion criteria for CRS-207 study on mesothelioma